Bristol-Myers Squibb opened expanded biologics facility in Devens
On May 17, 2016, Bristol-Myers Squibb completed an expansion at its Devens, MA biologics facility designed to accelerate…
On May 17, 2016, Bristol-Myers Squibb completed an expansion at its Devens, MA biologics facility designed to accelerate…
On Jul. 14, 2015, Benaroya Research Institute at Virginia Mason (BRI) announced that Carla J. Greenbaum, MD, had…
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…
On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
Apr. 1, 2008, a team of researchers from Stanford’s School of Medicine announced they had developed a new…
On Sept. 27, 2007, the FDA Amendments Act of 2007 amended the Federal Food, Drug, and Cosmetic Act…
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
On May 5, 2006, the Cancer Research Initiative was established in South Carolina, between MUSC, University of South…
In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
In 2004, the Sarah Cannon Research Institute was formed to bring together community-based physicians, researchers and clinicians to…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…